Constipation laxative Market

Constipation laxative Market Size Survey Report – In a Glance

As per the survey report on global Constipation laxative market, the market is projected to foresee a CAGR of CAGR value 6.1% between 2024-2033, and further generate a market size of USD 10.3 billion revenue by the end of 2033. In the year 2024, the market size was valued at USD 7.1 billion revenue.

• The global Constipation laxative market is projected to grow on account of the uptick in constipation cases.
• In Japan, the Constipation laxative market growth can be attributed to the soaring senior population.
• KDMI analyst’s growth analysis foresees risk of negative reactions to challenge the market growth.
• North America, having the highest market share in the Constipation laxative market, is projected to dominate the global market.

Constipation laxative Market Analysis

A constipation laxative is a form of medication or supplement used to ease constipation by improving bowel activity, hydrating the intestines, passing moistening stool, or increasing bowel contractions. It generally contains fiber boosters, stimulants, and stool softeners. Bowel irregularity is a common concern and a struggle for aging individuals. Also, functional constipation is prevalent among children, with about 29.6% prevalence globally and over a third of children show behavioral problems due to constipation. However, the uptick in constipation cases is due to several factors such as lack of physical activity, insufficient dietary fiber intake, and certain medical conditions like irritable bowel syndrome (IBS), hypothyroidism, or diabetes which fuels the global constipation laxative trade. Bayer AG, Abbott Laboratories, Sanofi S.A, are some of the significant parties in the global market for Constipation laxative .

Analyst’s Observation on Japan Constipation laxative Market Survey

On the global platform, the figure for the aging population is highest in Japan. Moreover, owing to lower gastric acid levels, higher medicine consumption, and slower digestive processes, aging adults are at a greater risk for gastrointestinal disorders. In addition, chronic constipation (CC) is a prolonged gut disorder with harmful impacts affecting everyday activities. According to the diagnostic standards, the incidence of CC is approximated to be 6.1–28% in Japan. Since older people are more likely to develop digestive ailments, the soaring senior population in the country is predominantly responsible for the growth of the constipation laxative market. Takeda Pharmaceutical Company Limited, Sanofi, Abbott Laboratories, are some of the significant parties in the market for Constipation laxative in Japan.

Constipation laxative Market Growth Drivers and Challenges

Growth Drivers

Rising reliance on laxatives:

Instead of adopting healthier dietary habits or lifestyles, many people opt for laxatives to get instant relief from constipation. Currently, health-aware consumers are increasingly embracing the trend of moving toward natural and herbal laxatives which is attracting many buyers to the market. Natural and herbal laxatives are mild with minimal side effects and eco-friendly benefits. Therefore, conscious consumers prefer them over artificial options for their digestive well-being. In addition, chronic constipation is common everywhere, with a projected prevalence value of 15%. As constipation cases are on the rise worldwide, there is an increased demand for constipation laxatives for quick relief, easy availability, and expected effectiveness. Moreover, the rising recognition of over-the-counter (OTC) laxatives as a safe and potent remedy for constipation has also increased the constipation laxative market presence globally.

Growing e-commerce and online marketing:

In the current era, the growth of online marketplaces like digital shopping platforms has made buying laxatives easier and more accessible for consumers. Online markets and e-commerce are flourishing due to increased accessibility of smartphones, broader internet reach, and seamless digital payments. This convenience of online shopping has fueled the constipation laxative market expansion by enabling laxative manufacturers to connect with a larger consumer base. It has been found that the e-commerce sales for B2B businesses have been progressively expanding year over year over the past decade across the world, with the global B2B e-commerce market value worth USD$36 trillion by 2026.This growing business-to-business commerce supports the laxative industry by broadening its supply channel, strengthening distribution networks, and increasing worldwide product reach.

Restraints

Risk of negative reactions:

Long-term and frequent consumption of laxatives can cause health issues such as loss of body fluids, salt imbalances, and addiction to laxatives. Other harmful effects include cramps, bloating, nausea, dizziness, fatigue, abdominal pain, and more. Therefore, fears among consumers about these potential side effects might make some individuals reluctant to opt for laxatives, limiting the constipation laxative market.

Presence of substitute treatments:

Constipation relief is not limited to laxatives. There are other alternatives to manage constipation such as diet modifications, proper hydration, fiber enrichment, routine physical activities, and regular intake of probiotics. Many individuals favour these natural and non-medicated alternatives, minimizing their reliance on laxatives. Therefore, this growing inclination towards natural substitutes may affect the market dynamics, limiting the constipation laxative market.

Constipation laxative Market Segmentation

Our experts at KD Market Insights have segmented the global Constipation laxative market research report as:

Constipation laxative Market Regional Synopsis

North America is at the forefront of the constipation laxative market and is majorly driven by the market presence of major firms and a surge in sanctioned drugs for constipation treatment. Moreover, the progressive healthcare systems, increased awareness among the public and favorable government initiatives in Canada and the United States further fuel the market within the region. According to estimates, the U.S. prevalence of inflammatory bowel disease (IBD) is calculated to be between 2.4 and 3.1 million approximately. The United States holds the largest share of the regional constipation laxative market within the given period because of the growing prevalence of gut disorders, increased demand for laxatives and digestive aids, and strong distribution channels.

Asia-Pacific (APAC) is encountering the quickest market surge during the forecasted period. The region functions as a central point for pharmaceutical businesses. This is mainly due to expansive distribution channels and trade connections. Furthermore, the market is also steered by the increasing use of generic drugs, consumer demands, economic expansion and progressing healthcare infrastructure. India is also upgrading the constipation laxative market due to its massive population, fast economic progression, and strengthened healthcare systems. In addition to that, Japan’s economic progress is likely to expand at a rate beyond its expected growth capacity due to its larger older demographic. China is also contributing a significant part to the regional market. It has implemented the world’s largest planned urban transformation program, thereby, promoting healthcare development. Also, numerous policies have supported its overall healthcare framework and economic growth goals.

In Europe, the existence of government organizations supporting healthcare development is mainly expected to drive constipation laxative market expansion in the coming future. Moreover, the UK is at the forefront of the development of the market in the region due to its increasing elderly demographic. Various factors are responsible for the market evolution in the area such as the rising occurrence of chronic diseases, heightened focus on personal wellness, and expanding market supply of medical solutions. Apart from these, due to surging sedentary lifestyles & bad food habits, growing awareness about wellness, and increasing accessibility of treatment & medications are some of the crucial factors for steering the market growth in Middle East & Latin America.

As per our analysts at KD Market Insights, the following five players lead the North America Constipation laxative market growth:

• Abbott (U.S.)
• Avrio Health L.P (U.S.)
• Prestige Consumer Healthcare Inc. (U.S.)
• Procter & Gamble (U.S.)
• Mallinckrodt (U.S.)

Constipation laxative Market Competitive Landscape

Some of the key players who top the global Constipation laxative market share:

• Bayer AG
• Abbott Laboratories
• Sanofi S.A
• GlaxoSmithKline Pharmaceuticals Ltd
• Mallinckrodt Pharmaceuticals
• Sebela Pharmaceuticals
• Beutlich Pharmaceuticals
• LLC
• Sun Pharmaceutical Industries Ltd
• Dr. Reddy’s Laboratories Ltd.

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Constipation Laxative Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Product type
      2. By Dosage form
      3. By Functionality
      4. By Distribution channel
      5. By End-user
      6. By Region
5. Market Segmentation by Product type
   1. 1. Stool Softeners
      2. Osmotic Laxatives
      3. Stimulant Laxatives
      4. Bulk-forming Laxatives
      5. Lubricant Laxatives
      6. Combination Laxatives
      7. Others
6. Market Segmentation by Dosage form
   1. 1. Tablets
      2. Capsules
      3. Powders
      4. Liquids
      5. Suppositories
      6. Enemas
      7. Others
7. Market Segmentation by Functionality
   1. 1. Immediate Relief
      2. Long-term Relief
      3. Preventive Measures
      4. Maintenance of Regular Bowel Movements
      5. Dietary Supplements for Digestive Health
      6. Others
8. Market Segmentation by Distribution channel
   1. 1. Pharmacies
      2. Supermarkets/Hypermarkets
      3. Online Retail
      4. Clinics and Hospitals
      5. Specialty Stores
      6. Others
9. Market Segmentation by End-user
   1. 1. Adults
      2. Children
      3. Geriatric Population
      4. Pediatric Patients
      5. Patients with Special Needs (e.g., those with chronic illnesses)
      6. Others
10. Regional Analysis
    1. North America
       1. United States
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       2. Canada
          1. Market Size and Forecast
          2. Key Trends and Developments
       3. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       4. Mexico
          1. Market Size and Forecast
          2. Key Trends and Developments
    2. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
    3. Europe
       1. United Kingdom
          1. Market Size and Forecast
          2. Key Trends and Developments
       2. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       3. Germany
          1. Market Size and Forecast
          2. Key Trends and Developments
       4. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       5. France
          1. Market Size and Forecast
          2. Key Trends and Developments
       6. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       7. Italy
          1. Market Size and Forecast
          2. Key Trends and Developments
       8. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       9. Spain
          1. Market Size and Forecast
          2. Key Trends and Developments
       10. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       11. Rest of Europe
           1. Market Size and Forecast
           2. Key Trends and Developments
    4. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
    5. Asia Pacific
       1. China
          1. Market Size and Forecast
          2. Key Trends and Developments
       2. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       3. Japan
          1. Market Size and Forecast
          2. Key Trends and Developments
       4. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       5. India
          1. Market Size and Forecast
          2. Key Trends and Developments
       6. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       7. Australia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
          4. South Korea
          5. Market Size and Forecast
          6. Key Trends and Developments
       8. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       9. Rest of Asia Pacific
          1. Market Size and Forecast
          2. Key Trends and Developments
    6. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
    7. Latin America
       1. Brazil
          1. Market Size and Forecast
          2. Key Trends and Developments
       2. Market Analysis Product type, Dosage form, Functionality, Distribution channel and End-user
       3. Argentina
          1. Market Size and Forecast
          2. Key Trends and Developments
       4. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       5. Colombia
          1. Market Size and Forecast
          2. Key Trends and Developments
       6. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       7. Rest of Latin America
          1. Market Size and Forecast
          2. Key Trends and Developments
    8. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
    9. Middle East & Africa
       1. South Africa
          1. Market Size and Forecast
          2. Key Trends and Developments
       2. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       3. Saudi Arabia
          1. Market Size and Forecast
          2. Key Trends and Developments
       4. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       5. UAE
          1. Market Size and Forecast
          2. Key Trends and Developments
       6. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
       7. Rest of Middle East & Africa
          1. Market Size and Forecast
          2. Key Trends and Developments
11. Market Analysis by Product type, Dosage form, Functionality, Distribution channel and End-user
12. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
    3. Bayer AG
    4. Abbott Laboratories
    5. Sanofi S.A
    6. GlaxoSmithKline Pharmaceuticals Ltd
    7. Mallinckrodt Pharmaceuticals
    8. Sebela Pharmaceuticals
    9. Beutlich Pharmaceuticals
    10. LLC
    11. Sun Pharmaceutical Industries Ltd
    12. Dr. Reddy’s Laboratories Ltd.
13. Strategic Recommendations
14. Appendix
    1. List of Tables
    2. List of Figures
15. References